Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brefel

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Brain : a Journal of Neurology|January 1, 1997
The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patientsO Rascol, U Sabatini, N Fabre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Consensus statement on the role of acute dopaminergic challenge in Parkinson's diseaseA Albanese, U Bonuccelli, C Brefel, et al.
Parkinsonism & Related Disorders|December 20, 2017
Abnormal pain perception in patients with Multiple System AtrophyF Ory-Magne, J Pellaprat, E Harroch, et al.
Brain : a Journal of Neurology|April 29, 1998
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesiaO Rascol, U Sabatini, C Brefel, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 15, 2010
Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's diseaseV Marchand-Pauvert, A Gerdelat-Mas, F Ory-Magne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 1998
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsyO Rascol, K Sieradzan, H Peyro-Saint-Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2001
Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's diseaseI Arnulf, M Vidailhet, A M Bonnet, et al.
British Journal of Clinical Pharmacology|May 13, 1998
Effect of food on the pharmacokinetics of ropinirole in parkinsonian patientsC Brefel, C Thalamas, S Rayet, et al.
European Journal of Neurology|April 19, 2006
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteersJ J Ferreira, K Desboeuf, M Galitzky, et al.
Stereotactic and Functional Neurosurgery|January 28, 2004
Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contactsP Cintas, M Simonetta-Moreau, F Ory, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Brain : a Journal of Neurology|January 1, 1997
The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patientsO Rascol, U Sabatini, N Fabre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Consensus statement on the role of acute dopaminergic challenge in Parkinson's diseaseA Albanese, U Bonuccelli, C Brefel, et al.
Parkinsonism & Related Disorders|December 20, 2017
Abnormal pain perception in patients with Multiple System AtrophyF Ory-Magne, J Pellaprat, E Harroch, et al.
Brain : a Journal of Neurology|April 29, 1998
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesiaO Rascol, U Sabatini, C Brefel, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 15, 2010
Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's diseaseV Marchand-Pauvert, A Gerdelat-Mas, F Ory-Magne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 1998
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsyO Rascol, K Sieradzan, H Peyro-Saint-Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2001
Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's diseaseI Arnulf, M Vidailhet, A M Bonnet, et al.
British Journal of Clinical Pharmacology|May 13, 1998
Effect of food on the pharmacokinetics of ropinirole in parkinsonian patientsC Brefel, C Thalamas, S Rayet, et al.
European Journal of Neurology|April 19, 2006
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteersJ J Ferreira, K Desboeuf, M Galitzky, et al.
Stereotactic and Functional Neurosurgery|January 28, 2004
Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contactsP Cintas, M Simonetta-Moreau, F Ory, et al.
Pageof 7